Relatório sobre Empreendedorismo na EUROACE 2014

As três regiões EUROACE superam o resto dos países europeus analisados no que diz respeito à educação e formação empreendedora. O Alentejo e o Centro também na transferência de R + D e no apoio ao financiamento. A Extremadura apesar de não ter uma avaliação positiva, apresenta um valor superior ao resto dos países baseados na inovação no que diz respeito às políticas e programas de governo regional para o empreendedorismo

Informe - El Empreendimento en La Eurorregión EUROACE 2014

El perfil del empreendedor de la Euroace es el de un hombre, de unos 38 años, con estudios secundarios, con un nivel de renta bajo (<20000 €) y que vive en un hogar de 3 persona

APOGEE Net: An Expanded Spectral Model of Both Low-mass and High-mass Stars

We train a convolutional neural network, APOGEE Net, to predict T eff, logg, and, for some stars, [Fe/H], based on the APOGEE spectra. This is the first pipeline adapted for these data that is capable of estimating these parameters in a self-consistent manner not only for low-mass stars, (such as main-sequence dwarfs, pre-main-sequence stars, and red giants), but also high-mass stars with T eff in excess of 50,000 K, including hot dwarfs and blue supergiants. The catalog of ∼650,000 stars presented in this paper allows for a detailed investigation of the star-forming history of not just the Milky Way, but also of the Magellanic clouds, as different type of objects tracing different parts of these galaxies can be more cleanly selected through their distinct placement in T eff-logg parameter space than in previous APOGEE catalogs produced through different pipelines. © 2022. The Author(s). Published by the American Astronomical Society.Open access journalThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at [email protected]

Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-U.S. institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p &lt; 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection